Functional Peptides – Chemistry, Synthesis, and Applications

Author:   C Sharma
Publisher:   Wiley-VCH Verlag GmbH
ISBN:  

9783527352517


Pages:   300
Publication Date:   17 January 2024
Format:   Hardback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $239.95 Quantity:  
Add to Cart

Share |

Functional Peptides – Chemistry, Synthesis, and Applications


Overview

Full Product Details

Author:   C Sharma
Publisher:   Wiley-VCH Verlag GmbH
Imprint:   Wiley-VCH Verlag GmbH
ISBN:  

9783527352517


ISBN 10:   3527352511
Pages:   300
Publication Date:   17 January 2024
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Dr.Chiranjeev Sharma currently works on PROTAC synthesis, enantioselective enzymatic synthesis of dinucleotides and synthesis of riboside analogues for anticancer and antimalarial drug discovery at Department of Medicinal Chemistry, Virginia Commonwealth University, USA. He also held the position of assistant professor (adjunct) at Keimyung University, Daegu and research professor at Sungkyunkwan University, Suwon where he was involved in anticancer drug discovery including design, synthesis, characterization, and purification of anticancer drugs, PROTACs and total synthesis of natural product analogues for antibody drug conjugation. Sang J. Chung is the Professor of Medicinal Chemistry and Biologics at Sungkyunkwan University since 2017. He received his Ph.D. degree in 1996 from POSTECH, South Korea, in the area of Bioorganic and Medicinal Chemistry. He carried out his post-doctoral research at the Scripps Research Institute and Harvard University. He established a research program in antibody-drug conjugate (ADC) using peptide linkers thereby finding a bio-venture company, AbTis developing ADC therapeutics, where he is Chief Executive Officer. His main research focus is on the development of ADC platform technology and novel peptide chemistry for therapeutics.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List